IGC Pharma, Inc. (IGC) income statement
IGCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 2/3017% above fair value
$0.18−0.01 (-5.45%)
Close on Nov 19, 2026Market cap $19.02MP/E –Yield –
IGC Pharma, Inc. financial ratios
See a number that looks wrong?